Risk Factor Analysis of Early-Onset Cataracts in Taiwan
Abstract
:1. Introduction
2. Materials and Methods
2.1. Research Subjects
2.2. Research Materials
2.3. Data Analysis and Statistical Analysis
3. Results
3.1. Background Possibility Risk Factors of EOC
3.1.1. Background Comparison between Groups
3.1.2. Family History Comparison between Three Groups
3.1.3. Healthy Status Comparison between Each Group
3.1.4. Lifestyle Habits and Drug Use Comparisons between Each Group
3.2. Psychological Possibility Risk Factors of EOC
3.3. Blood Possibility Risk Factors of EOC
3.4. Visual Function Possibility Risk Factors of EOC
3.5. Linear Regression Analysis on Predicting EOC
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ministry of Health and Welfare. National Health Insurance Medical Statistics; Ministry of Health and Welfare: Taipei, Taiwan, 2016.
- Carlson, N.B.; Kurtz, D. Clinical Procedures for Ocular Examination Ed4; McGraw-Hill: Taipei, Taiwan, 2004. [Google Scholar]
- Ting, C.Y.; Chiang, T.L. A Typology of Adult Population in Taiwan Based on Health Behavior Pattern-An Application of Cluster Analysis. Taiwan J. Public Health 1996, 06, 175–187. [Google Scholar]
- Ho, S.H.; Li, C.S. Analysis of the influence of socioeconomic factors and lifestyle on the sustained health of middle-aged and elderly people in Taiwan. Ling Tung J. 2007, 22, 1–32. [Google Scholar]
- Alam, M.S.; Kumar, K.P. Clozapine-induced cataract in a young female. J. Pharmacol. Pharmacother. 2016, 7, 184. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Praveen, M.; Shah, G.; Vasavada, A.; Mehta, P.G.; Gilbert, C.; Bhagat, G. A study to explore the risk factors for the early onset of cataract in India. Eye 2010, 24, 686–694. [Google Scholar] [CrossRef]
- Zhang, J.; Wang, W.; Yang, G.; Ha, J.; Tan, X.; Shang, X.; Zhu, Z.; Han, X.; Liu, Z.; Zhang, L.; et al. Body mass index is not associated with early onset cataract in the 45 and Up cohort study. Ann. Transl. Med. 2021, 9, 1640. [Google Scholar] [CrossRef]
- Kelly, S.P.; Thornton, J.; Edwards, R.; Sahu, A.; Harrison, R. Smoking and cataract: Review of causal association. J. Cataract Refract. Surg. 2005, 31, 2395–2404. [Google Scholar] [CrossRef]
- Lindblad, B.E.; Håkansson, N.; Svensson, H.; Philipson, B.; Wolk, A. Intensity of smoking and smoking cessation in relation to risk of cataract extraction: A prospective study of women. Am. J. Epidemiol. 2005, 162, 73–79. [Google Scholar] [CrossRef] [Green Version]
- Drews, R.C. Alcohol and Cataract. Arch. Ophthalmol. 1993, 111, 1312. [Google Scholar] [CrossRef]
- Hsieh, Y.C.; Chang, C.H.; Tsai, Y.Y.; Lin, C.L.; Ng, T.Y.; Chiang, C.C. Increased risk of tinnitus in patients with early-onset cataracts: A nationwide population-based case-control study. BMC Ophthalmol. 2020, 20, 230. [Google Scholar] [CrossRef]
- Huang, C.Y.; Chen, T.S.; Lin, C.L.; Hu, W.S. Does early onset cataract increase the risk of ischemic stroke? A nationwide retrospective cohort study. Intern. Emerg. Med. 2017, 12, 461–465. [Google Scholar] [CrossRef]
- Hu, W.S.; Lin, C.L.; Chang, S.S.; Chen, M.F.; Chang, K.C. Increased risk of ischemic heart disease among subjects with cataracts: A population-based cohort study. Medicine 2016, 95, e4119. [Google Scholar] [CrossRef] [PubMed]
- Liao, X.; Huang, X.; Lan, C.; Li, J.; Tan, Q. Characteristic Cataract Associated with Idiopathic Hypoparathyroidism. J. Clin. Exp. Ophthalmol. 2016, 7, 588. [Google Scholar] [CrossRef]
- Zhu, X.; Li, D.; Du, Y.; He, W.; Lu, Y. DNA hypermethylation-mediated downregulation of antioxidant genes contributes to the early onset of cataracts in highly myopic eyes. Redox Biol. 2018, 19, 179–189. [Google Scholar] [CrossRef] [PubMed]
- Das, G.K.; Boriwal, K.; Chhabra, P.; Sahu, P.K.; Kumar, S.; Kumar, N. Presenile cataract and its risk factors: A case control study. J. Fam. Med. Prim. Care 2019, 8, 2120–2123. [Google Scholar] [CrossRef]
- Chiang, C.C.; Lin, C.L.; Peng, C.L.; Sung, F.C.; Tsai, Y.Y. Increased risk of cancer in patients with early-onset cataracts: A nationwide population-based study. Cancer Sci. 2014, 105, 431–436. [Google Scholar] [CrossRef]
- Chen, H.L.; Chang, H.M.; Wu, H.J.; Lin, Y.C.; Chang, Y.H.; Chang, Y.C.; Lee, W.H.; Chang, C.T. Effect of hydrophilic and lipophilic statins on early onset cataract: A nationwide case-control study. Regul. Toxicol. Pharmacol. 2021, 124, 104970. [Google Scholar] [CrossRef]
- Papadopoulos, C.; Kekou, K.; Xirou, S.; Kitsiou-Tzeli, S.; Kararizou, E.; Papadimas, G.K. Early onset posterior subscapular cataract in a series of myotonic dystrophy type 2 patients. Eye 2018, 32, 622–625. [Google Scholar] [CrossRef] [Green Version]
- Kaur, J.; Kukreja, S.; Kaur, A.; Malhotra, N.; Kaur, R. The oxidative stress in cataract patients. J. Clin. Diagn. Res. 2012, 6, 1629–1632. [Google Scholar] [CrossRef]
- Owsley, C.; Stalvey, B.; Wells, J.; Sloane, M.E. Older drivers and cataract: Driving habits and crash risk. J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 1999, 54, M203–M211. [Google Scholar] [CrossRef] [Green Version]
- Allen, D.; Vasavada, A. Cataract and surgery for cataract. BMJ 2006, 333, 128–132. [Google Scholar] [CrossRef]
- Chou, P.-H.; Chu, C.-S.; Chen, Y.-H.; Hsu, M.-Y.; Huang, M.-W.; Lan, T.-H.; Lin, C.-H. Antidepressants and risk of cataract development: A population-based, nested case-control study. J. Affect. Disord. 2017, 215, 237–244. [Google Scholar] [CrossRef] [PubMed]
- Sunjic-Alic, A.; Zebenholzer, K.; Gall, W. Reporting of Studies Conducted on Austrian Claims Data. Stud. Health Technol. Inform. 2021, 279, 62–69. [Google Scholar] [CrossRef] [PubMed]
- Cuschieri, S. The STROBE guidelines. Saudi J. Anaesth. 2019, 13 (Suppl. S1), S31–S34. [Google Scholar] [CrossRef] [PubMed]
- Mamatha, B.S.; Nidhi, B.; Padmaprabhu, C.A.; Pallavi, P.; Vallikannan, B. Risk Factors for Nuclear and Cortical Cataracts: A Hospital Based Study. J. Ophthalmic. Vis. Res. 2015, 10, 243–249. [Google Scholar] [CrossRef] [Green Version]
- Park, S.; Choi, N.K. Timing of first childbirth and age-related cataract. Menopause 2017, 24, 996–1002. [Google Scholar] [CrossRef]
- Leske, M.C.; Chylack, L.T., Jr.; Wu, S.Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch. Ophthalmol. 1991, 109, 244–251. [Google Scholar] [CrossRef]
- Ughade, S.N.; Zodpey, S.P.; Khanolkar, V.A. Risk factors for cataract: A case control study. Indian J. Ophthalmol. 1998, 46, 221–227. [Google Scholar] [CrossRef]
- Sies, H. What is Oxidative Stress? In Oxidative Stress and Vascular Disease, Developments in Cardiovascular Medicine; Keaney, J.F., Ed.; Springer: Boston, MA, USA, 2000; Volume 224. [Google Scholar] [CrossRef]
- Hu, W.S.; Lin, C.L. Association Between Cataract and Risk of Incident Atrial Fibrillation: A Nationwide Population-Based Retrospective Cohort Study. Mayo Clin. Proc. 2017, 92, 370–375. [Google Scholar] [CrossRef]
- Davies, K.J. Oxidative stress: The paradox of aerobic life. Biochem. Soc. Symp. 1995, 61, 1–31. [Google Scholar] [CrossRef]
- Spector, A. Oxidative stress-induced cataract: Mechanism of action. FASEB J. 1995, 9, 1173–1182. [Google Scholar] [CrossRef] [Green Version]
- Sies, H. Oxidative stress: Oxidants and antioxidants. Exp. Physiol. 1997, 82, 291–295. [Google Scholar] [CrossRef]
- Oduntan, O.; Masige, K. A review of the role of oxidative stress in the pathogenesis of eye diseases. Afr. Vis. Eye Health 2011, 70, 191–199. [Google Scholar] [CrossRef] [Green Version]
- Pesudovs, K.; Elliott, D.B. Refractive error changes in cortical, nuclear, and posterior subcapsular cataracts. Br. J. Ophthalmol. 2003, 87, 964–967. [Google Scholar] [CrossRef] [PubMed]
- Samarawickrama, C.; Wang, J.J.; Burlutsky, G.; Tan, A.G.; Mitchell, P. Nuclear cataract and myopic shift in refraction. Am. J. Ophthalmol. 2007, 144, 457–459. [Google Scholar] [CrossRef] [PubMed]
- Law, S.K.; Wang, L.; Li, T. Acupuncture for glaucoma. Cochrane Database Syst. Rev. 2020, 2, CD006030. [Google Scholar] [CrossRef] [PubMed]
Number | % | Gender | Number | Average of Age | |
---|---|---|---|---|---|
Control group | 27 | 38.0% | Male | 12 | 45.17 ± 9.722 |
Female | 15 | 44.60 ± 4.388 | |||
Early-onset cataract (EOC) | 20 | 28.2% | Male | 12 | 49.92 ± 3.679 |
Female | 8 | 49.75 ± 4.464 | |||
Combined group (EOC + dry eye) | 24 | 33.8% | Male | 9 | 49.33 ± 3.536 |
Female | 15 | 49.40 ± 6.390 |
Controlling Age Variance | Groups | Pearson χ2 | p | |||
---|---|---|---|---|---|---|
Normal | Cataract | Combined | ||||
Hypertension | yes | 0 | 7 | 6 | 10.495 | 0.00 ** |
0.0% | 35.0% | 25.0% | ||||
no | 27 | 13 | 18 | |||
100.0% | 65.0% | 75.0% | ||||
Diabetes | yes | 0 | 3 | 4 | 4.799 | 0.05 * |
0.0% | 15.0% | 16.7% | ||||
no | 27 | 17 | 20 | |||
100.0% | 85.0% | 83.3% | ||||
Asthma | yes | 1 | 1 | 1 | 0.048 | 0.98 |
3.7% | 5.0% | 4.2% | ||||
no | 26 | 19 | 23 | |||
96.3% | 95.0% | 95.8% | ||||
Hyperlipidemia | yes | 0 | 2 | 0 | 5.248 | 0.04 * |
0.0% | 10.0% | 0.0% | ||||
no | 27 | 18 | 24 | |||
100.0% | 90.0% | 100.0% | ||||
Immune system disease | yes | 1 | 1 | 1 | 0.048 | 0.98 |
3.7% | 5.0% | 4.2% | ||||
no | 26 | 19 | 23 | |||
96.3% | 95.0% | 95.8% | ||||
Cancer | yes | 1 | 0 | 1 | 0.817 | 0.66 |
3.7% | 0.0% | 4.2% | ||||
no | 26 | 20 | 23 | |||
96.3% | 100.0% | 95.8% | ||||
High myopia | yes | 10 | 12 | 8 | 3.665 | 0.16 |
37.0% | 60.0% | 33.3% | ||||
no | 17 | 8 | 16 | |||
63.0% | 40.0% | 66.7% | ||||
High astigmatism | yes | 1 | 2 | 0 | 2.725 | 0.26 |
3.7% | 10.0% | 0.0% | ||||
no | 26 | 18 | 24 | |||
96.3% | 90.0% | 100.0% | ||||
Thyroid dysfunction | yes | 1 | 2 | 2 | 0.788 | 0.67 |
3.7% | 10.0% | 8.3% | ||||
no | 26 | 18 | 22 | |||
96.3% | 90.0% | 91.7% | ||||
Galactosemia | yes | 0 | 1 | 0 | 2.586 | 0.27 |
0.0% | 5.0% | 0.0% | ||||
no | 27 | 19 | 24 | |||
100.0% | 95.0% | 100.0% | ||||
Homo cystinuria | yes | 0 | 0 | 1 | 1.986 | 0.37 |
0.0% | 0.0% | 4.2% | ||||
no | 27 | 20 | 23 | |||
100.0% | 100.0% | 95.8% | ||||
Migraine | yes | 3 | 4 | 6 | 1.692 | 0.43 |
11.1% | 20.0% | 25.0% | ||||
no | 24 | 16 | 18 | |||
88.9% | 80.0% | 75.0% | ||||
Irritable Bowel Disorder | yes | 2 | 0 | 2 | 1.683 | 0.43 |
7.4% | 0.0% | 8.3% | ||||
no | 25 | 20 | 22 | |||
92.6% | 100.0% | 91.7% | ||||
Chronic pain | yes | 0 | 3 | 1 | 5.009 | 0.04 * |
0.0% | 15.0% | 4.2% | ||||
no | 27 | 17 | 23 | |||
100.0% | 85.0% | 95.8% | ||||
Head injury | yes | 1 | 2 | 1 | 1.004 | 0.61 |
3.7% | 10.0% | 4.2% | ||||
no | 26 | 18 | 23 | |||
96.3% | 90.0% | 95.8% | ||||
Other illnesses | yes | 3 | 8 | 9 | 6.299 | 0.04 * |
11.1% | 40.0% | 37.5% | ||||
no | 24 | 12 | 15 | |||
88.9% | 60.0% | 62.5% |
Controlling Age Variance | Groups | Pearson χ2 | p | |||
---|---|---|---|---|---|---|
Normal | Cataract | Combined | ||||
Steroid | yes | 1 | 2 | 2 | 1.291 | 0.53 |
3.7% | 10.0% | 8.3% | ||||
no | 26 | 18 | 22 | |||
96.30% | 90.00% | 91.70% | ||||
Anti-hypertensive drug pressure | yes | 0 | 7 | 5 | 10.420 | 0.00 ** |
0.0% | 35.0% | 20.8% | ||||
no | 27 | 13 | 19 | |||
100.0% | 65.00% | 79.20% | ||||
Amiodarone | yes | 0 | 1 | 0 | 2.586 | 0.27 |
0.0% | 5.0% | 0.0% | ||||
no | 27 | 19 | 24 | |||
100.0% | 95.0% | 100.0% | ||||
Antihistamine | yes | 1 | 4 | 1 | 4.804 | 0.05 |
3.7% | 20.0% | 4.2% | ||||
no | 26 | 16 | 23 | |||
96.3% | 80.0% | 95.8% | ||||
Hormone therapy | yes | 1 | 0 | 1 | 0.817 | 0.67 |
3.7% | 0.0% | 4.2% | ||||
no | 26 | 20 | 23 | |||
96.3% | 100.0% | 95.8% | ||||
Painkiller | yes | 1 | 3 | 4 | 2.523 | 0.28 |
3.7% | 15.0% | 16.7% | ||||
no | 26 | 17 | 20 | |||
96.3% | 85.0% | 83.3% | ||||
Other drugs | yes | 4 | 7 | 6 | 9.991 | 0.01 * |
14.8% | 35.0% | 25.0% | ||||
no | 23 | 13 | 18 | |||
85.2% | 65.0% | 75.0% |
Controlling Age Variance | Groups | Pearson χ2 | p | |||
---|---|---|---|---|---|---|
Normal | Cataract | Combined | ||||
GPx index | normal | 12 | 7 | 13 | 1.267 | 0.53 |
80.0% | 77.8% | 92.9% | ||||
abnormal | 3 | 2 | 1 | |||
20.0% | 22.2% | 7.1% | ||||
CRP index | normal | 15 | 7 | 8 | 7.856 | 0.02 * |
100.0% | 70.0% | 57.1% | ||||
abnormal | 0 | 3 | 6 | |||
0.0% | 30.0% | 42.9% | ||||
TAC index | normal | 10 | 7 | 12 | 1.512 | 0.47 |
66.7% | 70.0% | 85.7% | ||||
abnormal | 5 | 3 | 2 | |||
33.3% | 30.0% | 14.3% |
Dimension | χ2 | p | Cox R2 |
---|---|---|---|
Background | 9.889 | 0.042 | 0.125 |
Family disease | 35.470 | 0.003 | 0.341 |
Healthy status | 48.972 | 0.000 | 0.438 |
Medication | 39.619 | 0.001 | 0.373 |
Psychology | 13.510 | 0.009 | 0.149 |
Blood | 7.452 | 0.024 | 0.170 |
Eye examination | 18.685 | 0.001 | 0.215 |
Overall | 72.990 | 0.004 | 0.883 |
B | S.E. | Wald | p-Value | Exp(B) | ||
---|---|---|---|---|---|---|
BMI | EOC vs. Control | −1.043 | 0.606 | 2.961 | 0.085 | 0.352 |
Combined vs. Control | −1.873 | 0.648 | 8.357 | 0.004 ** | 0.154 | |
Educational level | EOC vs. Control | −1.456 | 0.733 | 3.949 | 0.047 * | 0.233 |
Combined vs. Control | −1.755 | 0.730 | 5.785 | 0.016 * | 0.173 | |
Family heart disease | EOC vs. Control | −2.165 | 0.987 | 4.812 | 0.028 * | 0.115 |
Combined vs. Control | −1.456 | 1.025 | 2.018 | 0.155 | 0.233 | |
Family hypertension | EOC vs. Control | −1.420 | 0.651 | 4.760 | 0.029 * | 0.242 |
Combined vs. Control | −0.780 | 0.620 | 1.580 | 0.209 | 0.459 | |
Family allergies | EOC vs. Control | −1.133 | 0.772 | 2.155 | 0.142 | 0.322 |
Combined vs. Control | −1.679 | 0.775 | 4.699 | 0.030 * | 0.187 | |
High myopia | EOC vs. Control | −1.950 | 0.758 | 6.625 | 0.010 * | 0.142 |
Combined vs. Control | −1.442 | 0.616 | 5.515 | 0.019 * | 0.143 | |
Other illness | EOC vs. Control | −1.900 | 0.830 | 5.235 | 0.022 * | 0.150 |
Combined vs. Control | −1.697 | 0.732 | 5.367 | 0.021 * | 0.183 | |
Other drugs | EOC vs. Control | −1.677 | 0.880 | 3.635 | 0.057 | 0.187 |
Combined vs. Control | −1.303 | 0.795 | 2.684 | 0.101 | 0.272 | |
Stress | EOC vs. Control | 1.182 | 0.504 | 5.505 | 0.019 * | 3.259 |
Combined vs. Control | 0.850 | 0.480 | 3.131 | 0.077 | 2.339 | |
CRP | EOC vs. Control | 6.307 | 3.689 | 2.923 | 0.087 | 548.43 |
Combined vs. Control | 6.337 | 3.657 | 3.003 | 0.083 | 565.38 | |
BCVA | EOC vs. Control | −12.207 | 5.620 | 4.718 | 0.030 * | 0.005 |
Combined vs. Control | −7.811 | 5.994 | 1.698 | 0.193 | 0.033 | |
Spherical equivalent | EOC vs. Control | 0.339 | 0.149 | 5.181 | 0.023 * | 1.404 |
Combined vs. Control | 0.242 | 0.106 | 5.202 | 0.023 * | 1.274 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tsai, L.-H.; Chen, C.-C.; Lin, C.-J.; Lin, S.-P.; Cheng, C.-Y.; Hsieh, H.-P. Risk Factor Analysis of Early-Onset Cataracts in Taiwan. J. Clin. Med. 2022, 11, 2374. https://doi.org/10.3390/jcm11092374
Tsai L-H, Chen C-C, Lin C-J, Lin S-P, Cheng C-Y, Hsieh H-P. Risk Factor Analysis of Early-Onset Cataracts in Taiwan. Journal of Clinical Medicine. 2022; 11(9):2374. https://doi.org/10.3390/jcm11092374
Chicago/Turabian StyleTsai, Lung-Hui, Ching-Chung Chen, Chien-Ju Lin, Sheng-Pei Lin, Ching-Ying Cheng, and Hsi-Pao Hsieh. 2022. "Risk Factor Analysis of Early-Onset Cataracts in Taiwan" Journal of Clinical Medicine 11, no. 9: 2374. https://doi.org/10.3390/jcm11092374
APA StyleTsai, L. -H., Chen, C. -C., Lin, C. -J., Lin, S. -P., Cheng, C. -Y., & Hsieh, H. -P. (2022). Risk Factor Analysis of Early-Onset Cataracts in Taiwan. Journal of Clinical Medicine, 11(9), 2374. https://doi.org/10.3390/jcm11092374